| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68 |
| filingDate |
1997-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14fbcdcdeae35a2dec4ce6f34cb9ee2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d930a3b04e3278873488efdeab3b0ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9d3fd4e52bcddab6f325c22fa98f42 |
| publicationDate |
2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2367307-T3 |
| titleOfInvention |
ANTIANGIOGENIC PEPTIDES POLINUCLEÓTIDOS THAT CODIFY THE SAME AND PROCEDURE TO INHIBIT ANGIOGENESIS. |
| abstract |
A compound having the formula A-B1-C1-X1-Y or a pharmaceutically acceptable salt or ester thereof, in which A is absent or is a nitrogen protecting group, Y is absent or is a carboxylic acid protecting group , B1 is absent or has 1 to 176 amino acid residues that occur naturally corresponding to the sequence of amino acid position 334 to amino acid position 513 of SEQ ID No. 1, C1 is the sequence of amino acid position 514 to amino acid position 523 of SEQ ID No. 1 and X1 is absent or has 1 to 10 amino acid residues that occur naturally corresponding to the sequence of amino acid position 524 to amino acid position 533 of SEQ ID No. 1; and homologs of the formula A-B1-C1-X1-Y that have at least 95% amino acid identity with the B1 C1-X1 fragment in which the homologues possess antiangiogenic activity. |
| priorityDate |
1996-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |